Cellexus
PrivateLast Round
Strategic
Apr 2, 2024
Total Funding Raised
$480,000
Company Overview
Cellexus operates in Healthcare & Life Sciences and is based in Dundee. Its latest recorded funding round was a Strategic round in April 2024.
Cellexus is a life sciences company that researches, develops, and manufactures single-use, airlift bioreactor systems and related technology.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellexus Comparables
Compare Cellexus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stobbe Group | 80% | |
| PBS Biotech | 79% | |
| OmniBRx Biotechnologies | 79% |
For institutional investors. Book with your work email.
Cellexus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 2, 2024 | ||||
| Grant | Jun 3, 2021 | ||||
| VC Round | Aug 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellexus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Scottish Investment Bank (Scottish Enterprise) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 48% MoM.
- Jan 31, 2026
Monthly visitors grew 42% MoM, reaching 2K.
For institutional investors. Book with your work email.
Cellexus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellexus's valuation, stock price, and market status.
Is Cellexus a public or private company?
Cellexus is a private company.
What is the current stock price of Cellexus?
Cellexus is a private company, so its shares have no public market price. Caplight tracks Cellexus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellexus worth (valuation)?
Valuation information for Cellexus is not publicly available.
Can I buy Cellexus stock?
Cellexus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellexus's last funding round?
Cellexus's most recent funding round was Strategic on April 2, 2024.
Who are the main investors in Cellexus?
Key investors in Cellexus include Innovate UK, Scottish Investment Bank (Scottish Enterprise).
Will Cellexus IPO soon?
No public IPO plans have been announced for Cellexus.
How can I track Cellexus secondary market activity?
Caplight tracks bids, offers, and trades in Cellexus's shares on secondary markets.